Hyun Jung Kwon

Title: Hyun Jung Kwon: Innovator in Protein Transduction Domains

Introduction

Hyun Jung Kwon is a notable inventor based in Gangneung-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of protein transduction domains. His work focuses on enhancing the efficiency of fusion compounds and their applications in pharmaceutical compositions.

Latest Patents

Hyun Jung Kwon holds a patent for a "Protein transduction domain, fusion compound containing the same, and pharmaceutical composition containing the fusion compound." This invention proposes a more efficient protein transduction domain and fusion compound. The research led to the discovery of a GK1 peptide comprising 18 amino acids, which can bond with high-molecular-weight materials such as proteins. This bonding allows these materials to penetrate living bodies, including cells, tissues, or blood, effectively. The fusion compound, oligonucleotide, or vector derived from this invention can be utilized in pharmaceutical compositions for preventing or treating diseases.

Career Highlights

Kwon's career is marked by his innovative research and development in the field of biotechnology. His work has led to advancements that could significantly impact medical treatments and drug delivery systems. He is associated with Genesen Co., Ltd., where he continues to contribute to groundbreaking research.

Collaborations

Hyun Jung Kwon has collaborated with notable colleagues, including Soo-Young Choi and Jin-Seu Park. Their combined expertise has fostered an environment of innovation and discovery in their research endeavors.

Conclusion

Hyun Jung Kwon's contributions to the field of protein transduction domains highlight his role as a leading inventor in biotechnology. His innovative work has the potential to transform pharmaceutical applications and improve treatment methodologies.